No abstract available
MeSH terms
-
Clinical Trials as Topic
-
Drug Approval
-
Drug Industry* / economics
-
Humans
-
Marketing*
-
Practice Guidelines as Topic*
-
Protein C / adverse effects
-
Protein C / therapeutic use*
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Research Support as Topic
-
Sepsis / drug therapy*
-
United States
-
United States Food and Drug Administration
Substances
-
Protein C
-
Recombinant Proteins
-
drotrecogin alfa activated